180 Life Sciences Corp (ATNF)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | ATNF | AZN | AMGN | GILD | BMY |
| Company | 180 Life Sciences Corp | Astrazeneca Plc | Amgen Inc | Gilead Sciences Inc | Bristol-Myers Squibb Company |
| Price Information | |||||
| Exchange | NASDAQ | NYSE | NASDAQ | NASDAQ | NYSE |
| Open | 6.84 | 198.71 | 340.99 | 139.00 | 59.12 |
| High | 7.24 | 200.00 | 341.32 | 139.31 | 59.23 |
| Low | 6.29 | 197.25 | 335.06 | 137.15 | 57.88 |
| Latest | 7.04 | 198.13 | 337.92 | 139.10 | 58.38 |
| Change | -0.57 | -4.70 | -4.65 | -1.03 | -0.95 |
| % Change | -7.49% | -2.32% | -1.36% | -0.74% | -1.60% |
| Volume | 11,633,900 | 667,757 | 447,863 | 686,103 | 1,466,299 |
| 20-Day Average Volume | 22,030,400 | 1,780,943 | 2,540,423 | 5,869,938 | 13,115,691 |
| Previous Close | 7.61 | 202.83 | 342.57 | 140.13 | 59.33 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | No | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 4.22 | 192.03 | 355.06 | 140.68 | 59.16 |
| 20-Day Raw Stochastic | 33.46% | 72.81% | 7.19% | 33.05% | 32.21% |
| 20-Day Relative Strength | 64.25 | 54.61 | 38.41 | 46.85 | 47.57 |
| Weighted Alpha | -64.46 | +47.52 | +17.52 | +33.20 | +20.78 |
| Today's Opinion | 88% Buy | 88% Buy | 24% Buy | 40% Buy | 56% Buy |
| Previous Opinion | 88% Buy | 88% Buy | 24% Buy | 40% Buy | 100% Buy |
| Last Month's Opinion | 16% Sell | 80% Buy | 88% Buy | 88% Buy | 88% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | +134.67% since 08/08/25 | +2.47% since 03/30/26 | -2.92% since 03/30/26 | +1.96% since 03/30/26 | -2.38% since 03/30/26 |
| Low | 2.94 on 08/11/25 | 193.55 on 03/31/26 | 335.62 on 04/07/26 | 137.17 on 04/07/26 | 57.88 on 04/07/26 |
| High | 17.46 on 08/13/25 | 204.75 on 04/06/26 | 357.00 on 04/01/26 | 141.49 on 04/01/26 | 62.22 on 04/01/26 |
| 1-Month | |||||
| %Chg | +687.38% since 07/15/25 | +2.29% since 03/06/26 | -8.31% since 03/06/26 | -3.42% since 03/06/26 | -3.28% since 03/06/26 |
| Low | 0.88 on 07/16/25 | 182.39 on 03/24/26 | 335.62 on 04/07/26 | 133.89 on 03/30/26 | 56.45 on 03/24/26 |
| High | 17.46 on 08/13/25 | 204.75 on 04/06/26 | 380.14 on 03/11/26 | 149.38 on 03/10/26 | 62.22 on 04/01/26 |
| 3-Month | |||||
| %Chg | +501.71% since 05/15/25 | +4.39% since 01/07/26 | -0.82% since 01/07/26 | +11.79% since 01/07/26 | +2.80% since 01/07/26 |
| Low | 0.70 on 07/07/25 | 178.08 on 01/21/26 | 319.79 on 01/13/26 | 119.33 on 01/09/26 | 53.54 on 01/21/26 |
| High | 17.46 on 08/13/25 | 212.71 on 02/18/26 | 391.29 on 03/02/26 | 157.29 on 02/11/26 | 62.89 on 03/02/26 |
| 6-Month | |||||
| %Chg | +429.32% since 02/14/25 | +15.68% since 10/07/25 | +14.65% since 10/07/25 | +19.04% since 10/07/25 | +30.56% since 10/07/25 |
| Low | 0.66 on 04/09/25 | 160.96 on 11/04/25 | 288.00 on 10/31/25 | 114.02 on 10/31/25 | 42.52 on 10/29/25 |
| High | 17.46 on 08/13/25 | 212.71 on 02/18/26 | 391.29 on 03/02/26 | 157.29 on 02/11/26 | 62.89 on 03/02/26 |
| Key Statistics | |||||
| Market Capitalization, $K | 42,516 | 314,570,656 | 184,668,512 | 173,932,464 | 121,136,144 |
| Shares Outstanding, K | 6,039 | 1,550,908 | 539,068 | 1,241,222 | 2,041,735 |
| Annual Sales | 0 | 58,739,000,000 | 36,751,000,000 | 29,443,000,000 | 48,194,000,000 |
| Annual Net Income | -6,170,000 | 10,225,000,000 | 7,711,000,000 | 8,510,000,000 | 7,054,000,000 |
| Last Quarter Sales | 0 | 15,503,000,000 | 9,866,000,000 | 7,925,000,000 | 12,502,000,000 |
| Last Quarter Net Income | -1,730,000 | 2,321,000,000 | 1,333,000,000 | 2,183,000,000 | 1,086,000,000 |
| 60-Month Beta | 0.38 | 0.35 | 0.47 | 0.39 | 0.27 |
| Per-Share Information | |||||
| Most Recent Earnings | -0.30 on 07/23/25 | 2.12 on 02/10/26 | 5.29 on 02/03/26 | 1.86 on 02/10/26 | 1.26 on 02/05/26 |
| Latest Earnings Date | 11/13/25 | 05/05/26 | 05/07/26 | 04/23/26 | 04/30/26 |
| Most Recent Dividend | N/A | 2.170 on 02/20/26 | 2.520 on 02/13/26 | 0.820 on 03/13/26 | 0.630 on 04/02/26 |
| Next Ex-Dividends Date | N/A | 02/20/26 | 05/15/26 | 03/13/26 | 04/02/26 |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 22.22 | 15.92 | 17.14 | 9.69 |